<DOC>
	<DOCNO>NCT01769482</DOCNO>
	<brief_summary>Current therapeutic option well-recognized group patient anginal symptoms—a positive exercise tolerance testing , SPECT perfusion defect MRI angiographically normal coronary arteries—are limit . The condition , refer microvascular angina ( MVA ) cardiac syndrome X , benign originally reported—patients present unstable angina nonobstructive atherosclerotic coronary artery disease 2 % risk death myocardial infarction 30 day follow-up . It common woman first presentation angina occur either perimenopausally postmenopausally . Aberrant flow-mediated coronary vasomotion pivotal pathogenesis ( systemic ) impairment endothelial function . Indeed , center use systemic assessment vascular function diagnostic pathway group woman . It recently suggest endothelial dysfunction may lead myocardial ischemia . In present study , investigator test hypothesis udenafil offer dual benefit improve vascular function lessen ischemia woman angina , perfusion defect cardiac MRI , normal coronary artery .</brief_summary>
	<brief_title>Understanding Chest Pain Microvascular Disease Proved Cardiac Magnetic Resonance Image</brief_title>
	<detailed_description>The aim study udenafil offer dual benefit improve vascular function lessen ischemia woman microvascular angina , perfusion defect cardiac MRI , normal coronary artery . The UMPIRE trial multi-center , prospective , randomize , placebo control trial , design evaluate effect udenafil improvement myocardial stress perfusion defect cardiac MRI , woman patient microvascular angina . A total 70 patient randomize udenafil ( 100 mg q ) placebo treatment . The primary end point study Change perfusion defect 25 % baseline defect adenosine-stress cardiac MRI 3-month treatment . The secondary endpoint study change perfusion defect le 25 % baseline defect adenosine-stress cardiac MRI 3-month treatment , decrement frequency chest pain , improvement ST-depression stress test , improvement duke score stress test , improvement QoL assessment SF-36 questionnaire , improvement sexual dysfunction assessment BISF-W self-questionnaire improvement biomarkers foe endothelial function .</detailed_description>
	<mesh_term>Chest Pain</mesh_term>
	<mesh_term>Udenafil</mesh_term>
	<criteria>1 . MVA patient typical symptom positive adenosinestress cardiac MRI normal coronary artery coronary angiogram coronary artery CT angiography . 2 . Definition positive adenosinestress MRI : perfusion defect &gt; 25 % transmurality ( 2 radiologist base visual assessment qualitative assessment corelab ) 3 . Gender : female 4 . Age : 1880 1 . The patient contraindication MR contrast medium MR Imaging 2 . LVEF &lt; 50 % 3 . Any heart rhythm abnormality sinus rhythm 4 . Valvular heart disease moderate degree 5 . Renal failure 6 . Congestive Heart Failure 7 . Myocardial infraction 8 . Myocarditis 9 . Congenital heart disease 10 . Pericarditis 11 . Variant angina ( positive provocation test Ergonovine acetylcholine ) 12 . GERD ( conform esophagogastroduodenoscopy ) 13 . Pregnant woman suspect , pregnant woman woman lactation 14 . QT prolongation syndrome take drug prolong QT interval Antiarrhythmics class IA ; quinidine , procainamide Antiarrhythmics class III ; amiodarone , sotalol 15 . Preanalytical within 30 day screen clinical trial may affect influence udenafil Other PDE5 inhibitor ( ex . Sildenafil , tadalafil ) Nitrates/ NO donor ( ex . Nitroglycerin , isosorbide mononitrate , isosorbide dinitrate , amyl nitrate/nitrite , sodium nitroprusside , nicorandil ) 16 . Preanalytical within 7 day screen clinical trial may affect metabolism udenafil Antibacterials ( ex . Erythromycin ) Antifungals ( ex . Itraconazole , ketoconazole ) Antivirals ( ex . Ritonavir , saquinavir , amprenavir , indinavir , nelfinavir ) Cimetidine Grapefruit juice 17 . Allergy sensitivity PDE 5 inhibitor</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>microvascular angina</keyword>
	<keyword>PDE-5 inhibitor</keyword>
	<keyword>Heart disease</keyword>
	<keyword>Ischemia</keyword>
	<keyword>Cardiac MRI</keyword>
</DOC>